TP53 and hepatocellular carcinoma: TP53 mutations and excessive methylation of the promoter area of this miRNA have been identified as underlying mechanisms of inactivation of miR-192-5p transcription in HCC cells and primary CSC-positive HCC (Gu et al., 2019).